Copper plays a fundamental role in the biochemistry of all aerobic organisms. The delivery of this metal to specific intracellular targets is mediated by metallochaperones. To elucidate the role of the metallochaperone Atox1, we analyzed mice with a disruption of the Atox1 locus. Atox1 ؊/؊ mice failed to thrive immediately after birth, with 45% of pups dying before weaning. Surviving animals exhibited growth failure, skin laxity, hypopigmentation, and seizures because of perinatal copper deficiency. Maternal Atox1 deficiency markedly increased the severity of Atox1 ؊/؊ phenotype, resulting in increased perinatal mortality as well as severe growth retardation and congenital malformations among surviving Atox1 ؊/؊ progeny. Furthermore, Atox1-deficient cells accumulated high levels of intracellular copper, and metabolic studies indicated that this defect was because of impaired cellular copper efflux. Taken together, these data reveal a direct role for Atox1 in trafficking of intracellular copper to the secretory pathway of mammalian cells and demonstrate that this metallochaperone plays a critical role in perinatal copper homeostasis.
C
opper is a transition element that plays an essential role in the metabolic pathways required for cellular respiration, iron homeostasis, pigment formation, neurotransmitter production, peptide biogenesis, connective tissue biosynthesis, and antioxidant defense (1) . Recognition of the inherited disorders of copper transport, Menkes and Wilson disease, dramatically underscored both the essential need for copper and the toxicity of this metal (2) . Characterization of the molecular genetic basis of these disorders has provided the opportunity to elucidate the molecular mechanisms of cellular copper metabolism, including the recent identification in Saccharomyces cerevisiae of a family of cytoplasmic proteins termed metallochaperones, proposed to play a role in intracellular copper trafficking (3, 4) .
Genetic and biochemical studies in yeast suggest that metallochaperones function to protect copper from intracellular scavenging while facilitating the appropriate partnerships with specific cupro-protein targets (5) . The yeast metallochaperone Atx1 plays a role in copper delivery to the secretory pathway in this organism via interaction with the copper transport ATPase Ccc2 (6) (7) (8) . Structural and functional analysis of the mammalian Atx1 homologue, ATOX1 (or HAH1), indicates that this protein interacts with the Menkes and Wilson copper-transporting ATPases located in the trans-Golgi network of cells (9, 10) . Analysis of Wilson disease-associated mutations in the amino terminus of the Wilson ATPase suggests a critical role for ATOX1-ATPase interaction in hepatocyte copper homeostasis (10) . Nevertheless, despite these experiments in yeast and in mammalian cell lines, the physiologic role of ATOX1 in mammals remains to be determined. This current study was undertaken to elucidate the function of ATOX1 in mammalian cells and to examine its role in cellular copper homeostasis by using a genetic mouse model.
Materials and Methods
Generation of Atox1 ؊͞؊ Null Mice. R1 embryonic stem cells were cultured and electroporated, and neomycin-resistant clones assayed positive for ␤-galactosidase activity were aggregated with morula-stage embryos to generate chimeric mice as described (11) . The genomic structure of mouse Atox1 has been reported (12) , and Southern blot and 5Ј-rapid amplification of cDNA ends analysis of genomic DNA from these embryonic stem cells confirmed the presence of the ␤-geo gene trap at the Atox1 locus. Chimeric mice were mated to CD-1 animals to obtain germ-line transmission of the disrupted Atox1 allele. Mice heterozygous for the trapped allele were backcrossed six times (N6) to C57BL͞6 mice and intercrossed seven times (F7). All subsequent analyses were performed with N6F7 generation mice. All mice were housed at the Washington University School of Medicine Vivarium under a 12-h light͞12-h dark cycle. Food and water were provided ad libitum, and all care was given in compliance with National Institutes of Health guidelines on the use of laboratory and experimental animals.
Genotyping and Analysis of Mice. Southern blot of wild-type (wt) and mutant genomic DNA digested with multiple restriction enzymes and analyzed with a 5Ј Atox1 probe confirmed that the ␤-geo insertion is at the Atox1 locus. Southern blot with a neomycin DNA probe revealed a single insertion of the ␤-geo cassette at the Atox1 locus. PCR was performed by two-allele, three-primer analysis by using genomic DNA template prepared from tail clips or embryonic tissues. PCR of the wt allele with primers (available on request) resulted in a 700-bp product, whereas PCR of the mutated allele resulted in a 1,300-bp fragment. Initial PCR results were verified by Southern analysis of genomic DNA from the same mice. RNA blot analyses were performed from total RNA isolated from E12.5 embryonic fibroblasts and hybridized with Atox1 or 18S DNA probe using Ultrahyb (Ambion, Austin, TX). Immunoblot analyses were performed by using ATOX1 antisera and chemiluminescent techniques (12) . No detectable Atox1 protein was observed in multiple tissues obtained from surviving Atox1 Ϫ/Ϫ animals. Growth was monitored by weighing animals starting from P0 to P30 every 24 h. Hypothermia was evaluated by the ability of mice to maintain body temperature at 4°C within a 3-h period by using a rectal digital thermometer. Milk spots were determined by examining the stomach contents of dissected P1 pups. For blood values, P1 pups were decapitated, and blood drawn into heparinized capillary tubes was used immediately to obtain hematocrits, sodium, and glucose values.
Radiolabeled Copper Studies. Placental copper transport studies were initiated in E14.5 timed pregnant dams by i.v. tail injection of 1 mCi of (chloride salt) in 100 l of saline (13, 14) . Twenty-four hours later, the individual placenta and embryo were dissected from the maternal tissues and rinsed three times with PBS before quantifying the amount of tissue 64 Cu incorporation in a Packard Gamma Counter. Each data point was calculated as the ratio of the amount of 64 Cu (cpm) retained within that tissue to the total amount of 64 Cu (cpm) injected into the mother. For cell culture experiments, mouse embryonic fibroblasts (MEFs) from E12.5 embryos were isolated and cultured in DMEM with 10% FCS as described (15) . After the first passage, the MEFs were genotyped by PCR analysis. Mouse fibroblast cell lines (802-5 and 802-1) were cultured as described (16) 64 Cu for 1 h as described above, followed by three quick rinses with prewarmed PBS to remove any residual copper, and then incubated with prewarmed OPTIMEM alone for several chase periods. Cells were harvested at different time intervals and processed for quantification as described for copper retention.
Copper and Enzyme Activity Measurements. Copper concentrations and enzymatic activities were measured from wt and Atox1 Ϫ/Ϫ P2 organs obtained from 5 litters (38 pups) of Atox1 ϩ/Ϫ matings. Total tissue copper content was measured by acid digestion of tissue and atomic absorption spectrophotometry (17) . Cytochrome c oxidase activity was measured spectrophotometrically on whole homogenates by monitoring loss of ferrocytochrome c (17) . Tyrosinase activity was measured in whole-skin homogenates as an in-gel dopa oxidase assay as described (18) . Succinate dehydrogenase activity was measured by the reduction of 2,6-dichlorophenol indophenol at 600 nm as described (19) . Limited tissue prohibited direct assay of lysyl oxidase or dopamine monooxygenase activities.
Results
To determine the physiologic role of ATOX1, we characterized a mouse Atox1 locus that was disrupted by gene-trap insertion of a ␤-galactosidase-neomycin marker (␤-geo) between the first and second exons of one allele of Atox1 in embryonic stem cells (Fig. 1A) (12, 20) . Germ-line chimeras derived from morula aggregation with the mutated cells were used to obtain heterozygous Atox1 ϩ/Ϫ mice that were bred to homozygosity and ascertained by Southern blot analysis of mouse genomic DNA by using a 5Ј Atox1-specific probe (Fig. 1B) and a neomycin DNA probe (data not shown). Analysis of mouse fibroblasts from E12.5 embryos indicated that the ␤-geo insertion resulted in an Atox1 null allele, as no Atox1 mRNA nor protein was detected in Atox1 Ϫ/Ϫ homozygous animals based on RNA blots and immunoblots, respectively ( Fig. 1 C and D) .
Analysis of staged offspring from Atox1 ϩ/Ϫ matings showed the expected Mendelian ratio until birth, but revealed a growth retardation phenotype in Atox1 Ϫ/Ϫ neonatal mice that was apparent in most pups by postnatal day 3 (P3) ( Fig. 2A) . Organ weight to body length comparison of mutant and wt littermates indicated that this growth impairment was symmetrical (data not shown). Despite normal sucking behavior, the presence of milk spots and normal red cell hemoglobin (hematocrit; ϩ͞ϩ 37.83 Ϯ 2B) . Despite the trend toward lower serum glucose values in Atox1 Ϫ/Ϫ pups, these values were within the normal range observed in newborn mice. Atox1 Ϫ/Ϫ pups displayed skin laxity, and some animals exhibited peripartum hemorrhaging, which contributed to the overall early mortality ( Fig. 2 C and D) . Genotyping of a total of 166 progeny from Atox1 ϩ/Ϫ intercrosses identified 49 Atox1 Ϫ/Ϫ pups, of which 33 survived beyond P3. Before weaning, an additional six animals died from prolonged seizure activity, giving an overall perinatal mortality of 45%. Unlike the Atox1 Ϫ/Ϫ mice, the growth, mortality, and gross phenotype of Atox1 ϩ/Ϫ mice were found to be indistinguishable from their wt littermates (data not shown). Beyond weaning, surviving Atox1 Ϫ/Ϫ mice remained growth-retarded, hypothermic, and hypopigmented (Fig. 2E) , suggesting long-term effects of perinatal Atox1 deficiency.
The phenotypes observed in Atox1
animals were in part similar to phenotypes observed in copper-deprived animals, indicating that perinatal copper homeostasis may be perturbed in the absence of Atox1. To examine copper homeostasis in Atox1 Ϫ/Ϫ mice, (Fig. 3A) . Transplacental nutrient uptake from the maternal circulation is mediated by syncytiotro- littermates. A similar phenotype of copper retention was observed when these studies were repeated with fibroblasts that were deficient in the Menkes ATPase (Fig. 3B) (21) . The difference in the amount of copper accumulated by the Menkes and Atox1 cells was not because of differences in copper uptake, as the initial rate for copper uptake was identical in wt and Atox1 Ϫ/Ϫ MEFs (Fig. 3C) . To further characterize the copperretaining phenotype of Atox1 Ϫ/Ϫ cells, MEFs were pulse labeled with 64 Cu for 1 h, and cells were analyzed at specific chase periods for 64 Cu retained. Atox1-deficient MEFs revealed a severe impairment in copper efflux compared with wt cells. Thus, Atox1 Ϫ/Ϫ cells accumulate copper because of defective copper efflux from the cell (Fig. 3D) .
A reduction in placental copper transport should result in newborn mice with decreased copper content in biosynthetically active tissues such as the neonatal liver and brain. Consistent with this concept, P2 Atox1 Ϫ/Ϫ pups had 50% less copper in the liver (mean Ϯ SD: ϩ͞ϩ, 20.2 Ϯ 4.12 g/g; Ϫ͞Ϫ, 10.1 Ϯ 1.71 g/g, P Ͻ 0.01) and in the brain (ϩ͞ϩ, 1.37 Ϯ 0.35 g/g; Ϫ͞Ϫ, 0.685 Ϯ 0.174 g/g, P Ͻ 0.01). Furthermore, the activity of essential cupro-enzymes including brain cytochrome oxidase (COX; ϩ͞ϩ, 0.42 Ϯ 0.02 unit/mg; Ϫ͞Ϫ, 0.267 Ϯ 0.03 unit/mg, P Ͻ 0.01) and tyrosinase (skin tissue from Ϫ͞Ϫ pups showed Ϸ25% of tyrosinase activity compared with ϩ͞ϩ littermates) was significantly decreased in P2 Atox1 Ϫ/Ϫ mice. The diminution in brain COX activity was not because of differences in mitochondrial number or integrity, as the activity of the inner mitochondrial membrane protein, succinate dehydrogenase, was normal (ϩ͞ϩ, 0.013 Ϯ 0.002 unit/mg, Ϫ͞Ϫ, 0.014 Ϯ 0.003 unit/mg).
As placental transfer of nutrients is often dependent on both maternal and fetal components, progeny from (Fig. 4A) . The phenotype in these Atox1 Ϫ/Ϫ mice was more severe than that observed previously in Atox1 Ϫ/Ϫ mice derived from heterozygote mothers, as evidenced by a near complete lack of tyrosinase enzyme activity in skin tissue (Fig. 4B) , despite the presence of normal amounts of tyrosinase protein in those (Fig. 4A) , significantly exacerbated the copper deficiency in Atox1 Ϫ/Ϫ pups. The concept of maternal Atox1 influence was supported by placental copper transport studies. As noted previously in Fig.  3A , the difference in 64 Cu distribution between the placenta and embryo was found to be dependent on the embryonic genotype (Fig. 4C) . However, now an overall reduction of 60% in copper availability for placental transport was observed in Atox1 (Fig. 4C) . Furthermore, some Atox1 Ϫ/Ϫ pups born to Atox1 Ϫ/Ϫ mothers demonstrated severe congenital eye defects (Fig. 4D) . Microphthalmia was observed in six Atox1 
Discussion
The data in this study demonstrate a critical role for the metallochaperone ATOX1 in mammalian copper homeostasis. The striking phenotypes observed in Atox1 Ϫ/Ϫ mice are in part similar to those observed in copper-deprived animals where diminished activity of the cupro-enzymes lysyl oxidase, dopamine monooxygenase, and tyrosinase results in impaired connective tissue integrity, temperature regulation, and pigment formation (1, 2) . The copper-retaining phenotype of Atox1-deficient MEFs reveals the cellular mechanism underlying the impaired placental copper transfer to Atox1 Ϫ/Ϫ embryos, where copper retention within the placenta, due to defective cellular copper efflux, results in decreased copper availability for the fetal circulation. These data, taken together with the demonstrated interaction between ATOX1 and the copper-transporting ATPases (9, 10), definitively reveal a role for ATOX1 in the pathway of copper trafficking from the cytoplasm to the secretory pathway in mammalian cells.
The seizures, hypothermia, and neurodegeneration observed in humans with Menkes disease, and in mice with mutations at the homologous mottled locus, have been attributed to regional alterations of COX activity secondary to copper deficiency in the neonatal brain (17, 22) . Thus, it is reasonable to assume that the morbidity associated with Atox1-deficient mice is in part related to reduced COX activity in specific areas of the brain that are metabolically active during development. Importantly, previous observations of the phenotype of different mottled alleles (Mo) have demonstrated a correlation between the type and severity of symptoms and the amount of in utero copper transferred to the developing fetus (23) . For example, dappled mice (Mo dp ) die in utero from impaired connective tissue integrity and hemorrhage secondary to a deficiency in lysyl oxidase activity, whereas brindled mice (Mo br ) have increased but variable neonatal mortality similar to that observed here in the Atox1 Ϫ/Ϫ mice. The heterogeneity in the phenotype in Atox1 Ϫ/Ϫ mice may potentially arise from incomplete penetrance resulting from either specific modifying genetic loci or epigenetic effects such as the amount of perinatal copper available during embryonic growth and development. The latter possibility then reveals phenotypic differences based on developmental and tissue-specific thresholds for copper requirement, a concept reinforced by data from Ctr1-deficient animals in the accompanying article (24) .
The finding that Atox1
mothers exhibited a more severe phenotype suggests that, in part, copper deficiency in Atox1 Ϫ/Ϫ mothers along with Atox1 deficiency in both maternal and fetal components within the placenta leads to a more acute deprivation of perinatal copper availability to the developing embryo, thus compounding the Atox1 Ϫ/Ϫ phenotype. Accordingly, these animals showed a marked impairment in growth, higher mortality, reduced pigmentation because of little or no tyrosinase activity, and microphthalmia. Although the precise role of Atox1 in eye development is unclear, a similar phenotype of hypopigmentation and microphthalmia is observed in mice deficient in Mitf, a transcription factor required for the development and maturation of the neural crest-derived melanocytes (25) . These findings then raise the possibility that copper-trafficking pathways involving Atox1 may play a role in the complex signal transduction events involved in neural crest cell development.
Our findings, together with previous biochemical studies (9, 10) , are consistent with the hypothesis that ATOX1 is required for copper trafficking to the secretory pathway of mammalian cells through interaction with the Menkes and Wilson ATPase. Thus, the severe pleiotropic phenotype in Atox1 deficiency may be because of impaired in utero copper delivery to both the Menkes and Wilson proteins during development. Furthermore, Atox1 may have additional roles during cell differentiation and survival, a concept supported by recent studies implicating a direct role for Atox1 in copper-dependent antioxidant and apoptotic defense in neurons (26) . The ability of excess copper to partially compensate for Atx1 deficiency in yeast (6) suggests that the phenotype observed in Atox1-deficient mice might also be affected by alterations in available copper. Preliminary studies administering i.p. copper to neonatal mice and weanling mice support this concept in that these animals demonstrate an improvement in survival and rescue of coat color. The microphthalmia and other developmental defects associated with Atox1 deficiency, and the embryonic lethality associated with loss of Ctr1 in the accompanying report (24) , reiterate the essential role for copper in fetal development. Current efforts are now focused on careful delineation of Atox1-associated phenotypes during tissue morphogenesis. In this regard, these studies underscore the unique potential of genetic models to contribute new knowledge to our understanding of the complex relationship between nutrition and fetal development. The observation that maternal genotype may contribute to differences in fetal copper acquisition and fetal development highlights an important complexity in considering genetic and environmental influences on nutrient delivery to the developing fetus. As such, the approach presented here provides a useful heuristic paradigm for defining the role of specific nutrients in the pathogenesis of birth defects, an area recently highlighted by the discovery of the role of folic acid in human fetal neural tube closure (27) .
